18 European countries and 34 partner organisations are working together to increase HPV vaccination coverage specially in regions with low coverage and to optimize data collection to monitor HPV vaccination coverage and the impact of vaccination.
Project duration: 30 months
1 November 2022 - 30 April 2025
Project management team: Istituto Superiore di Sanità (ISS), Italy
Dissemination team: Institute of Oncology Ljubljana, Slovenia
Official website: www.iss.it/perch
The General Objective of PERCH is to contribute to the implementation of Europe’s Beating Cancer Plan, which aims to support Member States’ efforts to extend the roll-out of routine HPV vaccination of girls and boys to eliminate cervical cancer and other cancers caused by HPV in the coming decade.
Improve capacities of Member States to plan and implement HPV vaccination campaigns by sharing knowledge and experience. Improve data and monitoring system on HPV vaccination and HPV screening. Improve knowledge and awareness on HPV-related disease and prevention in specific target groups (adolescent girls and boys). Improve knowledge and abilities for healthcare professionals in HPV vaccine communication.
PERCH will contribute to achieve the first objective of the “90-70-90” WHO cervical cancer elimination strategy, of reaching at least 90% of HPV vaccine coverage among girls by the age of 15 years.